References
- GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117–71.
- Saarilahti K, Kajanti M, Kouri M, Aaltonen LM, Franssila K, Joensuu H. Cyclin A and Ki-67 expression as predictors for locoregional recurrence and outcome in laryngeal cancer patients treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:986–95.
- Almadori G, Cadoni G, Galli J, Ferrandina G, Scambia G, Exarchakos G, et al. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Int J Cancer 1999;84:188–91.
- Elena F, Vassiliki K, Nikolaos A, Ilias K, Wirtz RM, Eleftheraki AG, et al. Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer. PLos One 2013;8:e70429.
- Jia G, Tao H, Rui-Hang M, Yu-Lin Z, Yi-Na J, Jing-Jing D, et al. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer. Int J Oncol 2014;44:481–90.
- Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 2011;140:1501–12.
- Markowski J, Oczkowojciechowska M, Gierek T, Jarzab M, Paluch J, Kowalska M, et al. Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays. J Physiol Pharmacol 2009;60(Suppl 1):57–63.
- Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:3.
- Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44–57.
- Peng S, Liu X, Yu J, Wan Z, Peng X. A new implementation of recursive feature elimination algorithm for gene selection from microarray data. Paper presented at the WRI World Congress on Computer Science and Information Engineering; 2009. pp 665–9.
- Rodrigo JP, Dominguez F, Suárez V, Canel M, Secades P, Chiara MD. Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007;133:145–50.
- Rodrigo JP, Álvarez-Alija G, Menéndez ST, Mancebo G, Allonca E, García-Carracedo D, et al. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy. Cancer Prev Res (Phila) 2011;4:1333–41.
- Raimondi C, Falasca M. Targeting PDK1 in cancer. Curr Med Chem 2011;18:2763–9.
- Pulkkinen JO, Penttinen M, Jalkanen M, Klemi P, Grénman R. Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol 1997;117:312–15.
- Klatka J. Syndecan-1 expression in laryngeal cancer. Eur Arch Otorhinolaryngol 2002; 259:115–18.
- Monji M, Kuratomi Y, Sato S, Kusano K, Inokuchi A. Distribution of lymphatic vessels in normal larynx and expression patterns of laminin gamma 2 in laryngeal cancer. Koutou 2008;20:57–61.
- Lohi J. Laminin-5 in the progression of carcinomas. Int J Cancer 2001;94:763–7.
- Uckun FM, Tibbles HE, Vassilev AO. Bruton's tyrosine kinase as a new therapeutic target. Anticancer Agents Med Chem 2007;7:624–32.
- Ye Y, Jumei S, Zhimin G, Salama ME, Satyabrata D, Erik W, et al. Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma. Cancer Res 2015;75:594–604.
- Kar Lok K, Kwong DL, Li F, Chan THM, Leilei C, Haibo L, et al. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma. Cancer Res 2010;70:8832–41.